AdaptHealth (NASDAQ:AHCO) Now Covered by Jefferies Financial Group

Jefferies Financial Group started coverage on shares of AdaptHealth (NASDAQ:AHCO) in a research report sent to investors on Tuesday, January 7th, BenzingaRatingsTable reports. The firm issued a buy rating and a $15.00 price target on the stock. Jefferies Financial Group also issued estimates for AdaptHealth’s Q4 2019 earnings at $0.11 EPS, FY2019 earnings at $0.11 EPS, Q1 2020 earnings at $0.08 EPS, Q2 2020 earnings at $0.10 EPS, Q3 2020 earnings at $0.12 EPS, Q4 2020 earnings at $0.16 EPS, FY2020 earnings at $0.46 EPS and FY2021 earnings at $0.75 EPS.

Other research analysts have also recently issued research reports about the stock. Deutsche Bank began coverage on shares of AdaptHealth in a report on Monday, December 9th. They set a buy rating and a $12.00 target price for the company. Svb Leerink began coverage on shares of AdaptHealth in a report on Wednesday, December 11th. They set an outperform rating and a $13.00 target price for the company. Finally, Leerink Swann began coverage on shares of AdaptHealth in a report on Wednesday, December 11th. They set an outperform rating and a $13.00 target price for the company.

Shares of NASDAQ:AHCO traded up $0.01 on Tuesday, hitting $11.31. 25 shares of the company were exchanged, compared to its average volume of 34,889. AdaptHealth has a 1-year low of $7.82 and a 1-year high of $12.77. The company has a market capitalization of $350.94 million, a P/E ratio of 141.38, a PEG ratio of 0.98 and a beta of 0.18.

AdaptHealth Company Profile

AdaptHealth, LLC distributes home medical equipment. The Company offers mobility products, respiratory therapy, non- invasive ventilation, nutrition supplies, ocean home health products, sleep therapy supplies, bed lifts, seat lift chairs, and bath aids. AdaptHealth, LLC was founded in 2012 and is based in Phoenixville, Pennsylvania.

Featured Article: Is it Safe to Invest in Commodities?

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.